Ann: Botanix Presents at Fall Clinical Dermatology Conference, page-46

Panic is contagious and some are probably confusing the general mood with a 'leak' on the trials progress.
On one side, some don't realize that there is a submitted protocol controlling the un-blinding of the data (being BTX1503's 'double blind') and that there is a strict Code of Conduct in place for participants in clinical trials that include the reporting of breach of protocol.
On the other, given that irrationality can pervade the market for quite some time, I'll have to keep accumulating at this prices and instead of getting that Alfa Romeo next year I'll be looking at buying a Bentley.